Future maternity in women experiencing anticancer therapy in childhood
Authors:
B. Mladosievičová; Ž. Mišíková; H. Bernadičová
Authors‘ workplace:
Ústav patologickej fyziológie LF UK, Bratislava
; II. detská klinika LF UK a DFNsP, Bratislava
*
Published in:
Prakt Gyn 2007; 11(2): 92-96
Overview
In industrialized countries, cancer incidence in childhood has increased and the number of cancer surviving patients has grown rapidly during past 3 decades. It is estimated that in 2010 every 250th person aged 2045 will be a former oncological patient. The aggression of anticancer therapy can lead to not only acute but also late consequences. It is therefore appropriate to prepare monitoring programs for former child oncological patients, achieving adulthood. Gynaecologists should play an important role in this follow up. The aim of this study is to give notice on late adverse consequences of anticancer therapy, important for the fertility of women, which underwent a successful anticancer treatment in childhood. The treat to future fertility, caused by anticancer therapy, significantly affects the woman’s life (fig. 1) [15].
Key words:
cancer therapy, child oncological patient, onco-gynaecology, fertility, therapy, prevention.
Sources
1. Bhatia S, Robison LL, Oberlin O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. New Engl J Med 1996; 334: 745-751.
2. Blatt J. Pregnancy outcome in long-term survivors of childhood cancer. Med Ped Oncol 1999; 33(1): 29-33.
3. Bleyer WA. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990; 40: 355-367.
4. Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Ped Oncol 1999; 33(1): 24-28.
5. Green DM, Peabody EM, Nana B et al. Pregnancy outcome after teatment for Wilm tumor: a report from the National Wilms Tumour Study Group. J Clin Oncol 2002; 20(10): 2506-2513.
6. Klener P. Klinicka onkologie. Praha: Galen 2002: 686.
7. Mladosievičová B, Foltinová A. Sekundárne malignity a kardiotoxicita. In: Ďuriš I, Hulín I, Bernadič M (eds). Princípy internej medicíny. Bratislava: SAP 2001: 3000.
8. Nygaard R, Clausen N, Siimes MA et al. Reproduction following treatment of childhood leukemia: a population-based prospective cohort study of fertility and offspring. Med Ped Oncol 1991; 19(6): 459-466.
9. Oeffinger KC, Eshelman DA, Tomlinson GE et al. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 2000; 88: 1687-1695.
10. Sanders JE, Pritchard S, Mahonez P et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total body irradiation and bone marrow transplantation. Blood 1996; 87(7): 3045-3052.
11. Schwartz CL. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 1999; 4: 45-54.
12. Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Ped Oncol 1999; 33: 1-8.
13. Sklar CA. Overview of the effects of cancer therapies: the nature, scale and breadth of the problem. Acta Paediat 1999; 433: 1-4.
14. Steliarova-Foucher E, Stiller C, Kaatsch P et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s: an epidemiological study. Lancet 2004; 364(9451): 2097-2105.
15. Stevens MCG, Mahler H, Parkes S. The health status of adult survivors of cancer in childhood. Eur J Cancer 1998; 34: 694-698.
16. Teinturier C, Hartmann O, Valteau-Couanet D et al. Ovarian function after autologous bone marrow transplantation in childhood: high dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998; 22(10): 989-994.
17. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005; 6: 209-218.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Practical Gynecology
2007 Issue 2
Most read in this issue
- Cerazette – practical experience
- Psychological and medical aspects of the birth of a dead foetus
- The influence of tibolonee on fibrocystic changes in the mammary gland
- Bisphosphonates in the therapy of bone metastases of breast carcinoma